CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 125 of 701 entries

View as:

Prolonging Remission in Depressed Elderly (PRIDE)

Phase: N/A Priority: Normal

NCT ID: NCT01028508 Org: User:

Start: 01/31/10 End: 03/31/16 Due: 03/31/17

Salud Integral Colombia

Phase: N/A Priority: Normal

NCT ID: NCT03119792 Org: User:

Start: 11/30/16 End: 02/13/18 Due: 02/13/19

Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy

Phase: N/A Priority: Normal

NCT ID: NCT00967629 Org: User:

Start: 06/30/09 End: 02/28/10 Due: 02/28/11

Proactive Palliative Care for Patients With Ventricular Assist Devices (VAD) and Their Families

Phase: N/A Priority: Normal

NCT ID: NCT01427634 Org: User:

Start: 07/31/11 End: 07/31/12 Due: 07/31/13

Comparing the Effectiveness of Two Therapies to Treat Signs of Anorexia Nervosa in Adolescents

Phase: N/A Priority: Normal

NCT ID: NCT00418977 Org: User:

Start: 09/30/05 End: 08/31/11 Due: 08/31/12

Light and the Effect on Metabolic Syndrome and Alzheimer's Disease

Phase: N/A Priority: Normal

NCT ID: NCT03777722 Org: User:

Start: 11/01/18 End: 05/31/25 Due: 05/31/26

Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies

Phase: N/A Priority: Normal

NCT ID: NCT03403036 Org: User:

Start: 10/31/17 End: 08/18/18 Due: 08/18/19

SURE 18 Registry -Asahi Chikai Black 18 in LVO Stroke

Phase: N/A Priority: Normal

NCT ID: NCT03438565 Org: User:

Start: 03/18/18 End: 02/01/20 Due: 02/01/21

High Flow Nasal Cannula Versus Bubble Nasal CPAP for the Treatment of Transient Tachypnea of the Newborn in Infants ≥ 35 Weeks Gestation

Phase: N/A Priority: Normal

NCT ID: NCT01270581 Org: User:

Start: 07/31/10 End: 04/30/12 Due: 04/30/13

Study to Treat Major Depressive Disorder (MDD) With a New Medication

Phase: N/A Priority: Normal

NCT ID: NCT02149836 Org: User:

Start: 08/31/14 End: 12/31/16 Due: 12/31/17

Daily Versus Every Other Day Glucose Monitoring in Gestational Diabetes Mellitus

Phase: N/A Priority: Normal

NCT ID: NCT04857073 Org: User:

Start: 04/10/21 End: 04/06/22 Due: 04/06/23

Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment

Phase: N/A Priority: Normal

NCT ID: NCT04263090 Org: User:

Start: 06/29/20 End: 12/20/23 Due: 12/20/24

Noom Health for Weight Management

Phase: N/A Priority: Normal

NCT ID: NCT04797169 Org: User:

Start: 03/22/21 End: 05/04/24 Due: 05/04/25

The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants

Phase: N/A Priority: Normal

NCT ID: NCT05223192 Org: User:

Start: 04/01/22 End: 03/31/26 Due: 03/31/27

Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC

Phase: N/A Priority: Normal

NCT ID: NCT06088771 Org: User:

Start: 03/08/24 End: 04/22/27 Due: 04/22/28

Mechanisms Underlying Predictors of Success From Obesity Surgery

Phase: N/A Priority: Normal

NCT ID: NCT02697253 Org: User:

Start: 01/31/16 End: 07/29/21 Due: 07/29/22

The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness

Phase: N/A Priority: Normal

NCT ID: NCT02423512 Org: User:

Start: 06/30/15 End: 06/13/17 Due: 06/13/18

The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer

Phase: N/A Priority: Normal

NCT ID: NCT01706939 Org: User:

Start: 09/01/12 End: 05/01/35 Due: 05/01/36

Long Acting Neuraxial Peri-prostatic Block in Cancer

Phase: N/A Priority: Normal

NCT ID: NCT06703437 Org: User:

Start: 12/13/22 End: 05/31/25 Due: 05/31/26

Guerbet Liver Fibrosis

Phase: N/A Priority: Normal

NCT ID: NCT06703450 Org: User:

Start: 02/28/24 End: 02/28/26 Due: 02/28/27

Computerized Cognitive Intervention in the Oldest-Old

Phase: N/A Priority: Normal

NCT ID: NCT03397498 Org: User:

Start: 03/10/11 End: 12/16/14 Due: 12/16/15

An Intuitive, Non-intrusive, Approach to Reduce Patient Harm From Inappropriate Dosing of High-risk Drugs in Older Adult Patients Across an Urban Safety Net Hospital System

Phase: N/A Priority: Normal

NCT ID: NCT05218343 Org: User:

Start: 02/16/22 End: 08/02/22 Due: 08/02/23

Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer

Phase: N/A Priority: Normal

NCT ID: NCT06040970 Org: User:

Start: 10/28/24 End: 09/07/26 Due: 09/07/27

STRIPES Study: Study To Reduce Infection Post cEsarean Section

Phase: N/A Priority: Normal

NCT ID: NCT02402907 Org: User:

Start: 04/30/15 End: 10/11/19 Due: 10/11/20

Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials

Phase: N/A Priority: Normal

NCT ID: NCT05146297 Org: User:

Start: 04/23/23 End: 03/31/26 Due: 03/31/27

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Prolonging Remission in Depressed Elderly (PRIDE)	NCT01028508	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2010-01-31	2016-03-31	2017-03-31	-	-	2025-07-14
Salud Integral Colombia	NCT03119792	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2016-11-30	2018-02-13	2019-02-13	-	-	2025-07-14
Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy	NCT00967629	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2009-06-30	2010-02-28	2011-02-28	-	-	2025-07-14
Proactive Palliative Care for Patients With Ventricular Assist Devices (VAD) and Their Families	NCT01427634	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2011-07-31	2012-07-31	2013-07-31	-	-	2025-07-14
Comparing the Effectiveness of Two Therapies to Treat Signs of Anorexia Nervosa in Adolescents	NCT00418977	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2005-09-30	2011-08-31	2012-08-31	-	-	2025-07-14
Light and the Effect on Metabolic Syndrome and Alzheimer's Disease	NCT03777722	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2018-11-01	2025-05-31	2026-05-31	-	-	2025-07-14
Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies	NCT03403036	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2017-10-31	2018-08-18	2019-08-18	-	-	2025-07-14
SURE 18 Registry -Asahi Chikai Black 18 in LVO Stroke	NCT03438565	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2018-03-18	2020-02-01	2021-02-01	-	-	2025-07-14
High Flow Nasal Cannula Versus Bubble Nasal CPAP for the Treatment of Transient Tachypnea of the Newborn in Infants ≥ 35 Weeks Gestation	NCT01270581	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2010-07-31	2012-04-30	2013-04-30	-	-	2025-07-14
Study to Treat Major Depressive Disorder (MDD) With a New Medication	NCT02149836	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2014-08-31	2016-12-31	2017-12-31	-	-	2025-07-14
Daily Versus Every Other Day Glucose Monitoring in Gestational Diabetes Mellitus	NCT04857073	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2021-04-10	2022-04-06	2023-04-06	-	-	2025-07-14
Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment	NCT04263090	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2020-06-29	2023-12-20	2024-12-20	-	-	2025-07-14
Noom Health for Weight Management	NCT04797169	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2021-03-22	2024-05-04	2025-05-04	-	-	2025-07-14
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants	NCT05223192	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2022-04-01	2026-03-31	2027-03-31	-	-	2025-07-14
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC	NCT06088771	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2024-03-08	2027-04-22	2028-04-22	-	-	2025-07-14
Mechanisms Underlying Predictors of Success From Obesity Surgery	NCT02697253	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2016-01-31	2021-07-29	2022-07-29	-	-	2025-07-14
The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness	NCT02423512	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2015-06-30	2017-06-13	2018-06-13	-	-	2025-07-14
The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer	NCT01706939	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2012-09-01	2035-05-01	2036-05-01	-	-	2025-07-14
Long Acting Neuraxial Peri-prostatic Block in Cancer	NCT06703437	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2022-12-13	2025-05-31	2026-05-31	-	-	2025-07-14
Guerbet Liver Fibrosis	NCT06703450	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2024-02-28	2026-02-28	2027-02-28	-	-	2025-07-14
Computerized Cognitive Intervention in the Oldest-Old	NCT03397498	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2011-03-10	2014-12-16	2015-12-16	-	-	2025-07-14
An Intuitive, Non-intrusive, Approach to Reduce Patient Harm From Inappropriate Dosing of High-risk Drugs in Older Adult Patients Across an Urban Safety Net Hospital System	NCT05218343	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2022-02-16	2022-08-02	2023-08-02	-	-	2025-07-14
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer	NCT06040970	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2024-10-28	2026-09-07	2027-09-07	-	-	2025-07-14
STRIPES Study: Study To Reduce Infection Post cEsarean Section	NCT02402907	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2015-04-30	2019-10-11	2020-10-11	-	-	2025-07-14
Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials	NCT05146297	Icahn School of Medicine at Mount Sinai	user2@example.com	None	2023-04-23	2026-03-31	2027-03-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance